Arkolith/Insider Trading/COAG/Form 4

Ra Capital Management, L.P.

10% OwnerHemab Therapeutics Holdings, Inc. (COAG) · full profile →Form 4 · filed May 21, 2026
Net Buying
Open-Market Buys
$120K
Open-Market Sells
$0
Net Open-Market Flow
$120K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 20, 2026Buy(P)996$24.94$25K6.4M
May 19, 2026Buy(P)4K$24.97$95K6.4M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-26-000521) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML